Prognostic significance and different properties of survivin splicing variants in gastric cancer

Cancer Letters

Volumn 216, Issue 2, 2004, Pages 147-155

  Meng, Hua ^a   Lu, Caide ^a   Mabuchi, Hideaki ^b   Tanigawa, Nobuhiko ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

AI, apoptotic index; Gastric cancer; IAP, inhibitor of apoptosis protein; PI, proliferative index; Real time quantitative RT PCR; Survivin splicing variants

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FROZEN SECTION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STATISTICAL SIGNIFICANCE; STOMACH CANCER; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, NEOPLASM; APOPTOSIS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN ISOFORMS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 7744234871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.12.020     Document Type: Article

References (27)

1. Rudin C.M., Thompson C.B. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48:1997;267-281
2. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:1997;917-921
3. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer. 3:2003;46-54
4. Velculescu V.E., Madden S.L., Zhang L., Lash A.E., Yu J., Rago C., et al. Analysis of human transcriptomes. Nat. Genet. 23:1999;387-388
5. Mahotka C., Wenzel M., Springer E., Gabbert H.E., Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59:1999;6097-6102
6. Lu C.D., Altieri D.C., Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58:1998;1808-1812
7. Nishi M., Omori Y., Miwa K. Japanese Classification of Gastric Carcinoma, First English edition. 1995;Kanehara&Co. Ltd, Tokyo
8. Kawasaki H., Toyoda M., Shinohara H., Okuda J., Watanabe I., Yamamoto T., et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer. 91:2001;2026-2032
9. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:1998;5071-5074
10. Mahotka C., Krieg T., Krieg A., Wenzel M., Suschek C.V., Heydthausen M., et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int. J. Cancer. 100:2002;30-36
11. Krieg A., Mahotka C., Krieg T., Grabsch H., Muller W., Takeno S., et al. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br. J. Cancer. 86:2002;737-743
12. Ikeguchi M., Kaibara N. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br. J. Cancer. 87:2002;883-887
13. Yu J., Leung W.K., Ebert M.P., Ng E.K., Go M.Y., Wang H.B., et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br. J. Cancer. 87:2002;91-97
14. Hirohashi Y., Torigoe T., Maeda A., Nabeta Y., Kamiguchi K., Sato T., et al. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin. Cancer Res. 8:2002;1731-1739
15. Kappler M., Kohler T., Kampf C., Diestelkotter P., Wurl P., Schmitz M., et al. Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int. J. Cancer. 95:2001;360-363
16. Mahotka C., Liebmann J., Wenzel M., Suschek C.V., Schmitt M., Gabbert H.E., Gerharz C.D. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 9:2002;1334-1342
17. Wakana Y., Kasuya K., Katayanagi S., Tsuchida A., Aoki T., Koyanagi Y., et al. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol. Rep. 9:2002;1213-1218
18. Rodriguez J.A., Span S.W., Ferreira C.G., Kruyt F.A., Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp. Cell Res. 275:2002;44-53
19. Wang H.W., Sharp T.V., Koumi A., Koentges G., Boshoff C. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Eur. Mol. Biol. Org. J. 21:2002;2602-2615
20. Asanuma K., Moriai R., Yajima T., Yagihashi A., Yamada M., Kobayashi D., Watanabe N. Survivin as a radioresistance factor in pancreatic cancer. Jpn. J. Cancer Res. 91:2000;1204-1209
21. Ikeguchi M., Kaibara N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int. J. Mol. Med. 8:2001;661-666
22. Kato J., Kuwabara Y., Mitani M., Shinoda N., Sato A., Toyama T., et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int. J. Cancer. 95:2001;92-95
23. Azuhata T., Scott D., Takamizawa S., Wen J., Davidoff A., Fukuzawa M., Sandler A. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J. Pediatr. Surg. 36:2001;1785-1791
24. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1998;882-883
25. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., Briere J., et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 96:2000;1921-1925
26. Chakravarti A., Noll E., Black P.M., Finkelstein D.F., Finkelstein D.M., Dyson N.J., Loeffler J.S. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 20:2002;1063-1068
27. Kamihira S., Yamada Y., Hirakata Y., Tomonaga M., Sugahara K., Hayashi T., et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br. J. Haematol. 114:2001;63-69